Evidence map›Paper›PMID 22266796›Full record

ArticleThe EMBO journal2012

Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence.

Melissa A Fischer, Isabel Moreno-Miralles, Aubrey Hunt, Brenda J Chyla, Scott W Hiebert

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The transcriptional corepressor CBFA2T3 inhibits all-The Journal of biological chemistry · 2020
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Changing mutational and adaptive landscapes and the genesis of cancer.Biochimica et biophysica acta. Reviews on cancer · 2017
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melissa A FischerDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Isabel Moreno-Miralles
Aubrey Hunt
Brenda J Chyla
Scott W Hiebert
Vanderbilt University · USUniversity of North Carolina at Chapel Hill · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of AML1-ETO in Acute LeukemiaR01CA064140 · NCI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 1994 to 2018
$5.7M
Function of Myeloid Translocation Gene Related-1R01CA112005 · NCI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 2005 to 2009
$1.6M
Function of MTG16/ETO2 in acute leukemiaR01HL088494 · NHLBI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 2007 to 2010
$1.5M
The Role of MTG16 in Thymocyte DevelopmentF30HL093993 · NHLBI · VANDERBILT UNIVERSITY · PI HUNT, AUBREY · 2008 to 2011
$144k
NCI NIH HHS P30 CA068485NCI NIH HHS P30CA68485NCI NIH HHS R01 CA064140NCI NIH HHS R01 CA112005NCI NIH HHS R01-CA112005NCI NIH HHS R01-CA64140NCRR NIH HHS UL1 RR024975NCRR NIH HHS UL1 RR024975-01NHLBI NIH HHS F30 HL093993NHLBI NIH HHS R01 HL088494NHLBI NIH HHS R01-HL088494NIDDK NIH HHS 5P30DK58404NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

The t(8;21) and t(16;21) that are associated with acute myeloid leukaemia disrupt two closely related genes termed Myeloid Translocation Genes 8 (MTG8) and 16 (MTG16), respectively. Many of the transcription factors that recruit Mtg16 regulate haematopoietic stem and progenitor cell functions and are required to maintain stem cell self-renewal potential. Accordingly, we found that Mtg16-null bone marrow (BM) failed in BM transplant assays. Moreover, when removed from the animal, Mtg16-deficient stem cells continued to show defects in stem cell self-renewal assays, suggesting a requirement for Mtg16 in this process. Gene expression analysis indicated that Mtg16 was required to suppress the expression of several key cell-cycle regulators including E2F2, and chromatin immunoprecipitation assays detected Mtg16 near an E2A binding site within the first intron of E2F2. BrdU incorporation assays indicated that in the absence of Mtg16 more long-term stem cells were in the S phase, even after competitive BM transplantation where normal stem and progenitor cells are present, suggesting that Mtg16 plays a role in the maintenance of stem cell quiescence.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsBinding SitesCells, CulturedE2F2 Transcription FactorGene ExpressionHematopoietic Stem CellsLeukemia, Myeloid, AcuteMiceMice, Inbred C57BLMice, NudeNuclear ProteinsRepressor ProteinsS PhaseTranscription FactorsBasic Helix-Loop-Helix ProteinsCbfa2t3 protein, mouseE2f2 protein, mouseE2F2 Transcription FactorNuclear ProteinsRepressor ProteinsTcf3 protein, mouseTranscription Factors

Identifiers

PMID22266796
PMCPMC3321173
OpenAlexW1778997321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.